When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no ...

   www.aol.com/fda-weight-loss-drug-zepbound...

   The FDA said Novo Nordisk's semaglutide, which is sold as Ozempic to treat diabetes and Wegovy for weight loss, remains on the agency's drug shortage list even though all versions of the drug are ...

3. US approves Lilly weight-loss drug, will compete with Novo's ...

   www.aol.com/news/us-fda-approves-lilly-weight...

   The FDA approved tirzepatide for weight loss under the brand name Zepbound. ... Eli Lilly shares have soared 67% in 2023 based on anticipation of approval of its drug for weight loss, making it ...

4. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

5. FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet - AOL

   www.aol.com/lifestyle/fda-approves-zepbound-most...

   Zepbound, made by Eli Lilly, is the newest FDA-approved drug for weight loss. (It was previously a diabetes treatment known as Mounjaro.) FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet

6. Woman opens up about losing 123 pounds with new weight loss ...

   www.aol.com/news/fda-approves-weight-loss-drug...

   On Nov. 8, the U.S. Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound, which, according to clinical trials, helped participants lose up to 52 pounds in 16 months.

7. Lilly's weight-loss drug removed from FDA's shortage list - AOL

   www.aol.com/news/us-fda-says-lillys-weight...

   Diabetes treatment Mounjaro has been on the health regulator's shortage list since late 2022, while weight-loss drug Zepbound was added in April as demand far outstripped supply. The limited ...